top of page
Experience The Possibilities
“The More Original A Discovery, The More Obvious It Seems Afterwards”
– Authur Koestler
“The More Original A Discovery, The More Obvious It Seems Afterwards”
– Authur Koestler
Cutting Edge Research Primed For ROI
EndoProtech is a Delaware company. It was founded in 2004 by Claudio Maldonado, Gustavo Perez-Abadia and Federico Grossi. To date, EndoProtech’s innovative therapies have been developed and funded with six Federal Phase I and Phase II SBIR grant awards from the National Institutes of Health. The company’s patent portfolio includes an awarded platform technology patent, and a patent to treat microvascular dysfunction.
bottom of page